1. Home
  2. VS vs BGLC Comparison

VS vs BGLC Comparison

Compare VS & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VS
  • BGLC
  • Stock Information
  • Founded
  • VS 2013
  • BGLC 2017
  • Country
  • VS United States
  • BGLC Malaysia
  • Employees
  • VS N/A
  • BGLC N/A
  • Industry
  • VS EDP Services
  • BGLC Medical Specialities
  • Sector
  • VS Technology
  • BGLC Health Care
  • Exchange
  • VS Nasdaq
  • BGLC Nasdaq
  • Market Cap
  • VS 10.1M
  • BGLC 10.7M
  • IPO Year
  • VS N/A
  • BGLC N/A
  • Fundamental
  • Price
  • VS $2.24
  • BGLC $7.18
  • Analyst Decision
  • VS Hold
  • BGLC
  • Analyst Count
  • VS 1
  • BGLC 0
  • Target Price
  • VS $2.00
  • BGLC N/A
  • AVG Volume (30 Days)
  • VS 28.0K
  • BGLC 3.5M
  • Earning Date
  • VS 08-13-2025
  • BGLC 08-13-2025
  • Dividend Yield
  • VS N/A
  • BGLC N/A
  • EPS Growth
  • VS N/A
  • BGLC N/A
  • EPS
  • VS N/A
  • BGLC N/A
  • Revenue
  • VS $230,132.00
  • BGLC $9,265,870.00
  • Revenue This Year
  • VS $3,459.21
  • BGLC N/A
  • Revenue Next Year
  • VS N/A
  • BGLC N/A
  • P/E Ratio
  • VS N/A
  • BGLC N/A
  • Revenue Growth
  • VS 64.71
  • BGLC N/A
  • 52 Week Low
  • VS $1.00
  • BGLC $2.01
  • 52 Week High
  • VS $9.59
  • BGLC $15.60
  • Technical
  • Relative Strength Index (RSI)
  • VS 40.57
  • BGLC 61.49
  • Support Level
  • VS $2.51
  • BGLC $4.40
  • Resistance Level
  • VS $2.83
  • BGLC $5.33
  • Average True Range (ATR)
  • VS 0.15
  • BGLC 0.84
  • MACD
  • VS -0.06
  • BGLC 0.01
  • Stochastic Oscillator
  • VS 0.00
  • BGLC 66.73

About VS Versus Systems Inc.

Versus Systems Inc offers a suite of proprietary business-to-business software tools that are meant to drive user engagement through gamification and rewards. These tools allow its partners to offer in-game prizes and rewards, including merchandise, coupons, digital goods, and sweepstakes entries - inside their websites, their venues, or their streaming media content. Its customers are mostly sports teams, venues, and advertising agencies, which typically use its products as part of their live events or as part of an advertising campaign with the goal of engaging fans, increasing consented first-party data, and increasing sales. The company operates in Canada and the USA.

About BGLC BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.

Share on Social Networks: